Literature DB >> 9192073

Bacterial overexpression, isotope enrichment, and NMR analysis of the N-terminal domain of human apolipoprotein E.

C A Fisher1, J Wang, G A Francis, B D Sykes, C M Kay, R O Ryan.   

Abstract

The nucleotide sequence encoding the N-terminal domain (residues 1-183) of human apolipoprotein E3 (apoE3) was cloned into the pET expression vector and introduced into Escherichia coli. Induction of protein expression with isopropyl beta-D-thiogalactopyranoside resulted in production of recombinant apoE3(1-183). Immunoblot analysis revealed that recombinant protein was present in both the cell pellet and cell culture supernatant. Analysis revealed that a significant portion of the rApoE3(1-183) in the cell pellet still possessed the bacterial N-terminal pel B leader sequence, encoded by plasmid DNA directly upstream of the apoE3(1-183) coding sequence. By contrast, this hydrophobic leader sequence had been removed from recombinant protein specifically accumulating in the culture medium. This behavior is novel for bacterial expression of apolipoprotein E and its truncated variants and permits efficient overexpression of the recombinant protein (> 100 mg/L cell culture). Recombinant apoE3(1-183) was isolated by a combination of heparin-Sepharose chromatography and reverse-phase HPLC. Electrospray mass spectrometry provided a mass of 21 191 daltons, corresponding directly to that expected from the known sequence. Circular dichroism spectroscopy revealed that the recombinant protein possesses significant amounts of alpha-helical secondary structure. The lipid binding ability of rApoE3(1-183) was evaluated using an in vitro lipoprotein binding assay. It was observed that recombinant apoE3(1-183) protected human low density lipoprotein (LDL) from lipid accumulation induced particle aggregation, indicating that it is capable of associating with lipoprotein surfaces. In addition, rApoE3(1-183) forms disk complexes with the model phospholipid dimyristoylphosphatidylcholine. In competition experiments, it was observed that rApoE3(1-183) phospholipid disks compete with 125I-LDL for binding to the apoB/E receptor on human skin fibroblasts to an extent similar to that observed for intact rApoE3. Taken together, these data show that recombinant apoE3(1-183) is fully functional as an apolipoprotein and receptor ligand. Given the high expression level and its known existence as a monomer in solution, we evaluated the potential for application of NMR spectroscopy to study the structure-function relationship of rApoE3(1-183). Bacteria were cultured in media supplemented with 15NH4Cl or [15N]glycine and the isotopically labeled recombinant apoE3(1-183) was analyzed by heteronuclear single quantum correlation NMR spectroscopy. The data revealed that rApoE3(1-183) is an excellent candidate for solution structure studies by NMR, including conformational adaptations associated with lipid association.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192073

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  15 in total

1.  Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.

Authors:  Kasuen Wong-Mauldin; Vincent Raussens; Trudy M Forte; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

2.  NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles.

Authors:  D Clayton; I M Brereton; P A Kroon; R Smith
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

3.  A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor.

Authors:  Taichi Yamamoto; Christine Lu; Robert O Ryan
Journal:  J Biol Chem       Date:  2010-12-11       Impact factor: 5.157

4.  Expressed protein ligation using an N-terminal cysteine containing fragment generated in vivo from a pelB fusion protein.

Authors:  Paul S Hauser; Robert O Ryan
Journal:  Protein Expr Purif       Date:  2007-04-10       Impact factor: 1.650

5.  Practical protocols for production of very high yields of recombinant proteins using Escherichia coli.

Authors:  Arun Sivashanmugam; Victoria Murray; Chunxian Cui; Yonghong Zhang; Jianjun Wang; Qianqian Li
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

6.  Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation.

Authors:  Paul S Hauser; Vincent Raussens; Taichi Yamamoto; Gezman E Abdullahi; Paul M M Weers; Brian D Sykes; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

7.  Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.

Authors:  Taichi Yamamoto; Hyung Won Choi; Robert O Ryan
Journal:  Anal Biochem       Date:  2007-09-11       Impact factor: 3.365

8.  ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.

Authors:  Mistuni Ghosh; Robert O Ryan
Journal:  Nanomedicine (Lond)       Date:  2013-07-24       Impact factor: 5.307

9.  Molecular studies of pH-dependent ligand interactions with the low-density lipoprotein receptor.

Authors:  Taichi Yamamoto; Hsuan-Chih Chen; Emmanuel Guigard; Cyril M Kay; Robert O Ryan
Journal:  Biochemistry       Date:  2008-10-11       Impact factor: 3.162

10.  Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E.

Authors:  Shiori Tamamizu-Kato; Jason Yiu Wong; Vikram Jairam; Koji Uchida; Vincent Raussens; Hiroyuki Kato; Jean-Marie Ruysschaert; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2007-06-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.